- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-182/17: Judgment of the General Court of 25 September 2018 — Novartis v EUIPO — Chiesi Farmaceutici (AKANTO) (EU trade mark — Opposition proceedings — Application for EU word mark AKANTO — Earlier EU word mark KANTOS — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001)
ECLI:EU:UNKNOWN:62017TA0182
62017TA0182
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
12.11.2018
Official Journal of the European Union
C 408/50
(Case T-182/17) (*)
((EU trade mark - Opposition proceedings - Application for EU word mark AKANTO - Earlier EU word mark KANTOS - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))
(2018/C 408/64)
Language of the case: English
Parties
Applicant: Novartis AG (Basel, Switzerland) (represented by: L. Junquera Lara, lawyer)
Defendant: European Union Intellectual Property Office (represented initially by: P. Duarte Guimarães and J. Ivanauskas, and subsequently by J. Ivanauskas and D. Walicka, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Chiesi Farmaceutici SpA (Parma, Italy) (represented by: T. de Haan, P. Péters, and F. Folmer, lawyers)
Re:
Action brought against the decision of the First Board of Appeal of EUIPO of 9 January 2017 (Case R 531/2016-1) relating to opposition proceedings between Chiesi Farmaceutici and Novartis.
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders Novartis AG to pay the costs.
(*)
Language of the case: English
(1) OJ C 161, 22.5.2017.
* * *